文献速递腹部技术与安全US

对比Sonazoid超声造影中ACR CEUS LI-RADS与改良LI-RADS对HCC的诊断效能

Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI-RADS and a Modified CEUS LI-RADS for HCC in Examinations Using Sonazoid.
PubMed 文献 · J Ultrasound Med · 2023-06-03

该回顾性研究纳入137例患者共140个结节,评估ACR CEUS LI-RADS(2017版)在Sonazoid造影中的可行性,并与改良LI-RADS比较。以LR-5预测HCC,两系统准确率分别为72.9%和71.4%(P=.50),敏感度均为69.7%;以LR-M预测非HCC恶性,准确率76.4%、敏感度73.3%。结论认为改良LI-RADS诊断效能中等,与ACR LI-RADS相当。

要点

  • LR-5预测HCC时,ACR与改良LI-RADS敏感度相同(69.7%,95%CI 60.7-77.8%)。
  • LR-M预测非HCC恶性时,两系统准确率76.4%、敏感度73.3%(95%CI 44.9-92.2%)。
  • Sonazoid造影下ACR CEUS LI-RADS诊断HCC效能与改良版相当。

核心结论

  • 改良LI-RADS在Sonazoid超声造影中对HCC具有中等诊断效能,与ACR CEUS LI-RADS相当。

研究设计与样本

  • 回顾性研究,纳入2020年1月至2022年2月137例患者共140个结节,均行Sonazoid超声造影并经手术或活检病理证实。
  • 以ACR CEUS LI-RADS(2017版)和改良LI-RADS为参考标准对病灶分类,计算准确率、敏感度、特异度、PPV、NPV及95%CI。

诊断标准与关键数值

  • 以LR-5预测HCC:ACR LI-RADS准确率72.9%,改良LI-RADS准确率71.4%(P=.50),两系统敏感度均为69.7%(95%CI 60.7-77.8%)。
  • 以LR-M预测非HCC恶性:两系统诊断效能相同,准确率76.4%,敏感度73.3%(95%CI 44.9-92.2%)。

临床应用与阅片要点

  • 在Sonazoid超声造影检查中,可参照ACR CEUS LI-RADS进行LR-5和LR-M分类。
  • 改良LI-RADS可作为Sonazoid造影下HCC诊断的替代分类系统,诊断效能与ACR版相当。

局限性

  • 回顾性研究设计。
  • 单中心样本,样本量有限(137例/140个结节)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The present study aimed to determine the feasibility of the American College of Radiology's (ACR) contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) (version 2017) in examinations using Sonazoid and compare its diagnostic performance with that of modified LI-RADS in patients at high risk of hepatocellular carcinoma (HCC).

METHODS: This retrospective study's sample population consisted of 137 participants with a total of 140 nodules who underwent CEUS with Sonazoid and pathological confirmation via surgery or biopsy from January 2020 to February 2022. The lesions were evaluated and classified based on the reference standards (ie, ACR CEUS LI-RADS and modified LI-RADS). The overall diagnostic capabilities of the two systems were evaluated in terms of accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with 95% confidence intervals (CIs).

RESULTS: The participants had a median age of 51 years and an interquartile range of 43-58 years. Regarding LR-5 as a predictor of HCC, the accuracy results of the ACR LI-RADS and modified LI-RADS algorithms were 72.9 and 71.4%, respectively (P = .50). The sensitivity of both systems was the same (69.7%; 95% CI: 60.7-77.8%). Regarding LR-M as a predictor of non-HCC malignancy, the diagnostic performance of the algorithms was the same, with accuracy and sensitivity results of 76.4 and 73.3%, respectively (95% CI: 44.9-92.2%).

CONCLUSION: The findings indicate that modified LI-RADS had a moderate level of diagnostic performance for HCC in examinations using Sonazoid, which was comparable to ACR LI-RADS.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Liao, Que, Wen, et al. Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI-RADS and a Modified CEUS LI-RADS for HCC in Examinations Using Sonazoid. J Ultrasound Med. 2023. PMID: 37269244. doi:10.1002/jum.16282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。